You can check and download them here:
Schedule for the oral presentations:
1. “Application of automated and validated virtual screening workflows: A hand-tool
for medicinal chemists to generate and/or evaluate ideas”
August 19, 2012 from 10:45 am to 11:05 am
Philadelphia Marriott Downtown, Room: 302/303
2. “Scaling drug discovery pipelines at mcule.com”
August 20, 2012 from 10:20 am to 10:50 am
Pennsylvania Convention Center, Room: 118 B
3. “Identifying novel JAK1 inhibitors by structure-based virtual screening: A case
study of using drug discovery tools at mcule.com”
August 22, 2012 from 10:45 am to 11:15 am
Pennsylvania Convention Center, Room: 117
4. “Evaluation of data quality in currently available compound libraries”
August 22, 2012 from 11:55 am to 12:15 pm
Philadelphia Marriott Downtown, Room: Conference Room 307
Schedule for the posters:
1. “Exploring the chemical space of histamine receptor ligands using drug discovery
tools at mcule.com”
August 19, 2012 from 7:00 pm to 9:00 pm
Pennsylvania Convention Center, Room: Hall D
2. “Application of automated and validated virtual screening workflows: A hand-tool
for medicinal chemists to generate and/or evaluate ideas”
August 20, 2012 from 8:00 pm to 10:00 pm
Pennsylvania Convention Center, Room: Hall D
3. “Evaluation of data quality in currently available compound libraries”
August 20, 2012 from 8:00 pm to 10:00 pm
Pennsylvania Convention Center , Room: Hall D
4. “Integration strategies for virtual and experimental screening. A case study on c-
Jun N-terminal kinase 3 (JNK3)”
August 21, 2012 from 6:00 pm to 8:00 pm
Pennsylvania Convention Center, Room: Hall G
5. “Identifying TRPV1 modulators by structure-based virtual screening: A case study of using drug discovery tools at mcule.com”
August 21, 2012 from 6:00 pm to 8:00 pm
Pennsylvania Convention Center, Room: Hall G
We wish to see you there and hope you will find our projects interesting!
Stay tuned for more information with mcule on:
Twitter: http://twitter.com/mculecom
Facebook: http://facebook.com/mculecom
The mcule team
No comments:
Post a Comment